A Case of C3 Nephritis With a Rare Variant of the CFHR5 Gene

Hisashi Kamido1, Shinya Yamamoto1, Hideki Yokoi1

  • 1Nephrology, Graduate School of Medicine, Kyoto University, Kyoto, JPN.

Cureus
|April 1, 2024
PubMed

Insights

C3 nephropathy, a kidney disease from complement pathway overactivation, often has a poor prognosis. A rare CFHR5 variant, P453S, may lead to a more stable renal outcome in patients.

Area of Science:

  • Nephrology
  • Immunology
  • Genetics

Background:

  • C3 nephropathy results from dysregulated alternative complement pathway activation.
  • Understanding C3 nephropathy pathogenesis is crucial for improving patient renal prognosis.
  • Genetic factors, including complement gene mutations and autoantibodies, are implicated in C3 nephropathy.

Observation:

  • A young woman presented with C3 nephritis.
  • She carried a heterozygous rare variant, P453S, in the CFHR5 gene.
  • The P453S variant is located in a critical functional region of the CFHR5 protein.

Findings:

  • In silico analyses suggested the pathological significance of the P453S variant.
  • The patient's renal function remained stable.
  • The P453S variant may impair CFHR5 protein function, leading to gradual complement activation.

Implications:

  • This case highlights the potential for certain genetic mutations to influence C3 nephropathy progression.
  • The P453S variant might be associated with a more favorable renal prognosis in C3 nephritis.
  • Further research into CFHR5 variants could refine prognostic predictions and therapeutic strategies for C3 nephropathy.